Faruqi & Faruqi, LLP announced on March 22 that it is investigating potential claims against Pomdoctor Limited and reminded investors of an approaching deadline to seek the role of lead plaintiff in a federal securities class action. The law firm said the deadline for Pomdoctor investors to act is April 13, 2026.
The case concerns individuals who purchased or acquired securities in Pomdoctor between October 9, 2025 and December 11, 2025. According to the announcement, affected investors are encouraged to contact Faruqi & Faruqi partner James (Josh) Wilson directly by phone to discuss their legal rights.
“If you purchased or acquired securities in Pomdoctor between October 9, 2025 and December 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310),” the statement said.
The press release was distributed through PR Newswire, which operates in more than 170 countries and supports distribution in over 40 languages according to the official website. PR Newswire aims to deliver global reach for press release distribution through its network of newsrooms and influencers according to the official website. The company features expert editors with over a decade of experience providing around-the-clock support and SEO guidance as reported by the official website.
PR Newswire collaborates with more than half a million media outlets and influencers globally according to the official website. Its services include press release distribution, AI-enhanced content tools, and social sharing features as outlined on its official website.
Investors interested in participating as lead plaintiffs or seeking further information are advised by Faruqi & Faruqi to reach out before the April deadline.
